Acadia Pharmaceuticals Inc

ACAD

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001070494

SEC filings (opens in a new tab)

In the last 90 days, Acadia Pharmaceuticals Inc insiders filed 0 open-market purchases and 2 sales; 354 institutions reported holding it in 13F filings for Q2 2026, worth $4.27B in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Acadia Pharmaceuticals Inc changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of ACAD: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Of which not filed for Q4 2022	Q4 2022	Change
Holders	223	2	228	+7
Shares	152.4M	2.11K	155.8M	+3.39M (+2.2%)
Value	$2.49B	$35.0K	$2.48B	−$13.0M (−0.5%)

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Acadia Pharmaceuticals Inc at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ACAD in Q4 2022
Institution	Shares	Value	% of portfolio
Braidwell LP	1,493,121	$23.8M	0.80%
Point72 Asset Management, L.P.	1,115,900	$17.8M	0.07%
Ally Bridge Group (NY) LLC	474,741	$7.56M	7.35%
Sector Gamma AS	185,835	$2.96M	0.68%
International Biotechnology Trust PLC	100,000	$1.59M	0.49%
AlphaCentric Advisors LLC	50,000	$796.0K	0.79%
Qube Research & Technologies Ltd	30,721	$489.1K	0.00%
Arete Wealth Advisors, LLC	17,278	$275.1K	0.02%
NinePointTwo Capital	16,702	$265.0K	0.11%
First Republic Investment Management, Inc.	15,085	$240.2K	0.00%
Raymond James Financial Services Advisors, Inc.	14,670	$233.5K	0.00%
Marex Group plc	12,232	$194.7K	0.03%
Two Sigma Investments, LP	11,137	$177.3K	0.00%
Martingale Asset Management L P	10,374	$165.2K	0.00%
State of Wyoming	5,784	$92.1K	0.03%
Balyasny Asset Management LLC	2,578	$41.0K	0.00%
Hollencrest Capital Management	1,500	$23.9K	0.00%
Coppell Advisory Solutions LLC	600	$9.55K	0.00%
Coppell Advisory Solutions Corp.	600	$9.55K	0.00%
Farther Finance Advisors, LLC	254	$4.04K	0.00%
TCI Wealth Advisors, Inc.	219	$3.49K	0.00%
GWM Advisors LLC	409	$3.33K	0.00%
Grove Bank & Trust	200	$3.00K	0.00%
Corrado Advisors, LLC	155	$2.47K	0.00%
Accurate Wealth Management, LLC	113	$1.96K	0.00%
Proequities, Inc.	100	$1.59K	0.00%
Baldwin Brothers Inc	100	$1.59K	0.00%
Belpointe Asset Management LLC	100	$1.59K	0.00%
Natixis	1	$16	0.00%
Steward Financial Group LLC	19	$0	0.00%

Sold out (23)

Institutions that held Acadia Pharmaceuticals Inc at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of ACAD in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Boxer Capital, LLC	1,263,930	$20.7M
Fairmount Funds Management LLC	751,804	$12.3M
Squarepoint Ops LLC	475,921	$7.79M
Woodline Partners LP	395,549	$6.47M
UBS Asset Management Americas Inc	123,201	$2.02M
Susquehanna Fundamental Investments, LLC	70,900	$1.16M
AlphaCrest Capital Management LLC	35,044	$573.0K
Crown Advisors Management, Inc.	30,000	$490.0K
Seven Eight Capital, LP	26,935	$441.0K
Dynamic Technology Lab Private Ltd	21,618	$354.0K
Aquatic Capital Management LLC	17,800	$291.0K
Prudential Financial Inc	17,296	$283.0K
Fox Run Management, L.L.C.	14,920	$244.0K
Creative Planning	13,202	$216.0K
Jump Financial, LLC	13,100	$214.0K
Lazard Asset Management LLC	3,689	$60.0K
Allworth Financial LP	820	$13.0K
Quadrant Capital Group LLC	435	$7.00K
Bartlett & Co. LLC	100	$2.00K
Prestige Wealth Management Group LLC	100	$2.00K
Bartlett & Co. Wealth Management LLC	100	$1.64K
Howe & Rusling Inc	54	$1.00K
Signaturefd, LLC	20	$0

Not filed for Q4 2022 yet (2)

Institutions that held Acadia Pharmaceuticals Inc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ACAD in Q3 2022 that haven't filed for Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Wipfli Financial Advisors LLC,	2,009	$33.0K
American Research & Management Co.	100	$2.00K